Benchmark (BMK) Share Price, News & Analysis

Company Overview

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.We bring together biology and technology to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

Key Stats

• Today's Range: 16 to 20
• 50-Day Range: 19.20 to 24.80
• 52-Week Range: 16 to 44.47
• Volume: 285,192 shs
• Average Volume: 292,155 shs
• Market Capitalization: £148.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BMK Stock Analysis - Frequently Asked Questions

How have BMK shares performed this year?

Benchmark's stock was trading at GBX 33.25 at the beginning of 2025. Since then, BMK shares have decreased by 39.8% and is now trading at GBX 20.

How were Benchmark's earnings last quarter?

Benchmark Holdings plc (LON:BMK) issued its quarterly earnings data on Thursday, June, 12th. The company reported ($1.77) EPS for the quarter. Benchmark had a negative net margin of 43.67% and a negative trailing twelve-month return on equity of 16.05%.

How do I buy shares of Benchmark?

Shares of BMK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Benchmark own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Benchmark investors own include Indivior (INDV), Allena Pharmaceuticals (ALNA), Clinigen Group (CLIN), Ampliphi Biosciences (APHB), Babcock International Group (BAB), Bigblu Broadband (BBB) and B&M European Value Retail (BME).

Company Calendar

• Last Earnings: 6/12/2025
• Today: 8/11/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: N/A
• Current Symbol: LON:BMK
• CIK: N/A
• Web: www.benchmarkplc.com
• Phone: +44-114-2409935
• Fax: N/A
• Employees: 823
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (5.34)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.91
• P/E Growth: -19.62
• Net Income: -£39.55 million
• Net Margins: -43.67%
• Pretax Margin: N/A
• Return on Equity: -16.05%
• Return on Assets: -1.07%

Debt

• Debt-to-Equity Ratio: 33.02
• Current Ratio: 1.73
• Quick Ratio: 1.41

Sales & Book Value

• Annual Sales: £90.57 million
• Price / Sales: 1.64
• Cash Flow: GBX 2.70 per share
• Price / Cash Flow: 7.41
• Book Value: GBX 30.32 per share
• Price / Book: 0.66

Miscellaneous

• Outstanding Shares: 741,272,999
• Free Float: N/A
• Market Cap: £148.25 million
• Optionable: Not Optionable
• Beta: 0.69